Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05020106

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Sponsor: Capital Medical University

View on ClinicalTrials.gov

Summary

The participant in this study includes Alzheimer's disease (AD including familial AD and sporadic AD) patients, amnestic mild cognitive impairment (aMCI) patients, non-AD dementia patients and cognitively normal control. The purpose of this study is to establish the best cut-off value of cerebrospinal fluid (CSF) and blood β-amyloid (Aβ) 42/40, total tau (t-tau) , phosphorylated tau ,inflammatory factors, etc. in diagnosis of Alzheimer's disease (AD).

Official title: Study on the Diagnostic Cut-off Value of Core Biomarkers in Cerebrospinal Fluid and Blood of Alzheimer's Disease

Key Details

Gender

All

Age Range

55 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

3200

Start Date

2018-09-01

Completion Date

2027-09-01

Last Updated

2026-03-23

Healthy Volunteers

Yes

Locations (1)

Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China